Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

ERIE vs RYAN: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

ERIE Captures Overall Composite Edge (47.8 HOLD vs 40.7 SELL), While RYAN Leads 5–1 on Growth & Valuation Pillars

ERIE Overall Winner 6-Pillar Tally: ERIE 1 – 5 RYAN Matrix Metrics: ERIE 6 – 4 RYAN

As of Nov 16, 2026, Erie Indemnity Co (ERIE) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (47.8/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 6–4 (led by Options & Positioning), while RYAN wins 5–1 across the 6-pillar growth and valuation breakdown. ERIE trades at $275.90 (20.7x Forward P/E, 18.3% operating margin) versus RYAN at $47.86 (19.7x Forward P/E, 19.8% operating margin).

  • Growth vs. Quality Trade-Off: ERIE earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. RYAN 40.7/100 SELL) and -0.51β · 38% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About ERIE vs RYAN
ERIE NASDAQ Head-to-Head Winner
Erie Indemnity Co
Insurance Agents, Brokers & Service
$275.90
+0.43% 1D
Market Cap $14.4B
TTM Revenue $4.12B
Forward P/E 20.7x
Beta / 30D Vol -0.51β · 38% Vol
Unified Composite Score
47.8 / 100 HOLD
Tech 28.0 Fund 46.0 Flow 65.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (0.9% over 20 days), RSI 64
RSI-14: 63.6 · SMA20: $263.74 · SMA50: $244.94
RYAN NYSE
Ryan Specialty Holdings, Inc.
Insurance Agents, Brokers & Service
$47.86
+2.07% 1D
Market Cap $11.9B
TTM Revenue $6.20B
Forward P/E 19.7x
Beta / 30D Vol -0.32β · 39% Vol
Unified Composite Score
40.7 / 100 SELL
Tech 22.0 Fund 38.0 Flow 50.0 Mom 50.0
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.6% over 20 days), RSI 67
RSI-14: 66.9 · SMA20: $45.34 · SMA50: $41.30

6-Pillar Scorecard Institutional Category Breakdown (ERIE 1 – 5 RYAN)

Columns: Metric · ERIE · RYAN
1. Valuation Multiples RYAN
Forward P/E 20.7x 19.7x
Trailing P/E 24.9x 58.6x
PEG Ratio 2.67x N/M
EV / Revenue 3.5x 1.9x
2. Growth & Scale RYAN
Revenue Growth (YoY) +0.3% +4.8%
Earnings Growth (YoY) -0.5% +43.1%
TTM Revenue (USD) $4.12B $6.20B
Market Cap $14.4B $11.9B
3. Profitability & Quality RYAN
Gross Margin 17.9% 41.1%
Operating Margin 18.3% 19.8%
Net Profit Margin 14.0% 3.3%
Return on Equity (ROE) 23.7% 25.1%
4. Balance Sheet & Cash Flow RYAN
Cash Generation (TTM) $554M $1.77B EBITDA
Cash Flow Margin 13.4% 28.5% EBITDA Mgn
Net Cash / Leverage $48.82 Book/Sh · 23.7% ROE $3.71 Book/Sh · 25.1% ROE
Dividend Yield 2.17% 1.11%
5. Options & Positioning ERIE
Options Structure Phase SURGE UNCLASSIFIED
Current IV / %ile 38.9% (6th %ile) 29.7% (12th %ile)
Put/Call OI Skew 0.01x (Call-Skewed) N/A
OBV Trend / Tech Phase NEUTRAL · Markup NEUTRAL · Markup
6. R&D & Supply-Chain Moat RYAN
OpEx & R&D Intensity N/A 21.3% of Rev ($1.32B)
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Scale & Operating Efficiency Moat Scale & Operating Efficiency Moat
Supply-Chain Role Insurance Brokers Operator Insurance Brokers Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: ERIE (6) vs RYAN (4)
Institutional Metric ERIE RYAN Criterion Row Edge
Market Capitalization
Scale
$14.4B $11.9B Larger Scale ERIE
Trailing P/E Ratio
Valuation
24.9x 58.6x Lower Multiple ERIE
Forward P/E Ratio
Valuation
20.7x 19.7x Lower Multiple RYAN
Revenue Growth (YoY)
Growth
+0.3% +4.8% Higher Growth RYAN
Operating Margin (TTM)
Profitability
18.3% 19.8% Higher Margin RYAN
Net Profit Margin
Profitability
14.0% 3.3% Higher Margin ERIE
Return on Equity (ROE)
Capital Efficiency
23.7% 25.1% Higher ROE RYAN
52-Week Range Position
Momentum
74% ($205–$302) 63% ($29–$59) Stronger Trend ERIE
Beta / 30D Volatility
Risk Regime
-0.51β · 38% Vol -0.32β · 39% Vol Lower Realized Risk ERIE
Unified Institutional Score
Composite Signal
47.8 / 100 (HOLD) 40.7 / 100 (SELL) Higher Composite ERIE
Trailing 12M Revenue (USD)
Operating Scale
$4.12B $6.20B FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
17.9% 41.1% Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
2.67x PEG · 3.5x EV/Rev N/M PEG · 1.9x EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
$554M ($48.82 Book/Sh · 23.7% ROE) $1.77B EBITDA ($3.71 Book/Sh · 25.1% ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon RYAN +4.24 pp
ERIE: +13.21% · RYAN: +17.45%
3M Horizon RYAN +8.67 pp
ERIE: +7.38% · RYAN: +16.05%
6M Horizon RYAN +17.58 pp
ERIE: +24.56% · RYAN: +42.14%
1Y Horizon ERIE +11.9 pp
ERIE: -3.93% · RYAN: -15.83%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on ERIE vs RYAN. Trailing 12-month operating profitability (ERIE 18.3% vs RYAN 19.8%) and valuation multiples (ERIE 20.7x vs RYAN 19.7x Forward P/E) are benchmarked directly in Pillar 4 below.

ERIE ADR TTM Benchmark FX-Normalized USD
TTM Revenue$4.12B
Gross Margin17.9%
Op. Margin18.3%
ROE / Fwd P/E23.7% · 20.7x
RYAN ADR TTM Benchmark FX-Normalized USD
TTM Revenue$6.20B
Gross Margin41.1%
Op. Margin19.8%
ROE / Fwd P/E25.1% · 19.7x

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
ERIE SURGE
7d in phase · OBV NEUTRAL
Current IV 38.9%
IV Percentile 6th %ile
Put/Call OI Skew 0.01x (Call-Skewed)
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal BULLISH
OBV Flow NEUTRAL
Exact ERIE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
RYAN UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 29.7%
IV Percentile 12th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact RYAN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
ERIE Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $14.4B market capitalization and 18.3% operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
RYAN Moat Profile Scale & Operating Efficiency Moat
Insurance Brokers Operator
Competes within the Insurance Brokers value chain with $11.9B market capitalization and 19.8% operating margin.
OpEx & R&D Reinvestment 21.3% of Rev ($1.32B)
90D Engineering Disclosures 0 Published

Investor FAQ ERIE vs RYAN Key Questions & Quantitative Answers

As of Nov 16, 2026, Erie Indemnity Co (ERIE) captures the overall head-to-head institutional edge over Ryan Specialty Holdings, Inc. (RYAN) on higher Unified Composite conviction (47.8/100 HOLD vs. 40.7/100 SELL) after splitting the core matrix 6–4 (led by Options & Positioning), while RYAN wins 5–1 across the 6-pillar growth and valuation breakdown. ERIE trades at $275.90 (20.7x Forward P/E, 18.3% operating margin) versus RYAN at $47.86 (19.7x Forward P/E, 19.8% operating margin). Growth vs. Quality Trade-Off: ERIE earns the overall head-to-head edge with a stronger Unified Composite Score (47.8/100 HOLD vs. RYAN 40.7/100 SELL) and -0.51β · 38% Vol risk profile, whereas RYAN leads top-line expansion (+4.8% YoY revenue growth, N/M PEG, and 5 of 6 institutional pillars) for higher-beta growth mandates.

RYAN leads the Growth & Scale pillar: ERIE posts +0.3% YoY revenue growth and -0.5% YoY earnings growth on $4.12B TTM revenue (17.9% gross margin, 18.3% operating margin), compared with RYAN at +4.8% YoY revenue growth and +43.1% YoY earnings growth on $6.20B TTM revenue (41.1% gross margin, 19.8% operating margin). On trailing 12-month operating scale, ERIE generates $4.12B in USD-normalized revenue versus $6.20B for RYAN. In operating R&D and SG&A reinvestment, ERIE deploys N/A (0 90-day corporate R&D disclosures) versus 21.3% of Rev ($1.32B) (0 disclosures) for RYAN.

RYAN screens cheaper on headline valuation multiples. ERIE trades at 20.7x Forward P/E, 24.9x Trailing P/E, 2.67x PEG, and 3.5x EV/Revenue (13.4% FCF margin), whereas RYAN trades at 19.7x Forward P/E, 58.6x Trailing P/E, N/M PEG, and 1.9x EV/Revenue (28.5% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against ERIE (23.7% ROE) versus RYAN (25.1% ROE) capital efficiency.

In options market volatility and institutional positioning, ERIE carries 38.9% implied volatility (6th %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a SURGE options structure phase (-0.51β · 38% Vol realized risk). By comparison, RYAN carries 29.7% implied volatility (12th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.32β · 39% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.